India, April 29 -- Stock of LifeMD, Inc. (LFMD) is climbing about 25 percent on Tuesday following the company's announcement regarding access to Wegovy through NovoCare Pharmacy.
The company's stock is currently trading at $7.64, up 25.33 percent or $1.55, over the previous close of $6.10 on the Nasdaq. The stock has traded between $3.99 and $12.88 in the last 52 weeks.
The company expects the plan to meet the growing demand among cash-pay patients for convenient access to clinically backed FDA-approved obesity treatment options.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....